img
Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors      
Yazarlar
Nebih Lolak
Adıyaman Üniversitesi, Türkiye
Süleyman Akocak
Adıyaman Üniversitesi, Türkiye
Mustafa Durgun
Harran Üniversitesi, Türkiye
Doç. Dr. Hatice Esra DURAN Doç. Dr. Hatice Esra DURAN
Kafkas Üniversitesi, Türkiye
Adem Necip
Türkiye
Cüneyt Türkeş
Erzincan Binali Yıldırım Üniversitesi, Türkiye
Mesut Işık
Bilecik Şeyh Edebali Üniversitesi, Türkiye
Şükrü Beydemir
Anadolu Üniversitesi, Türkiye
Özet
To discover alternative substances to compounds used to treat many diseases, especially treating Alzheimer's disease (AD) and Parkinson's disease targeting carbonic anhydrase (hCA) and acetylcholinesterase (AChE) enzymes, is important. For this purpose, a series of novel bis-ureido-substituted sulfaguanidine (SG1-4) and sulfisoxazole (SO1-4) derivatives were synthesized, and their inhibitory capacities were screened against hCA isoenzymes (hCA I and II) and AChE. Possible binding mechanisms of inhibitors to the active site were elucidated by in silico studies, and the results were supported by in vitro results. Moreover, the percent radical scavenging capacities of the derivatives were also evaluated. The derivatives (SG1-4 and SO1-4) were more effective against hCAs compared to standard drug acetazolamide (K values of 98.28-439.17 nM for hCA I and II, respectively) and exhibited the highest inhibition with the Ks in the ranges of 2.54 ± 0.50-41.02 ± 7.52 nM for hCA I, 11.20 ± 2.97-67.14 ± 13.58 nM for hCA II, and 257.60 ± 27.84-442.60 ± 52.13 nM for AChE. Also, compounds SG1 and SO1 also showed ABTS radical scavenging activity at the rate of 70% and 78%, respectively. These results will contribute to the literature for the rational design and synthesis of new potent and selective inhibitors targeting hCAs and AChE with multifunctional effects such as radical scavenging as well as inhibition. This study focused on the synthesis and inhibitory effects of bis-ureido-substituted sulfaguanidine (SG1-4) and sulfisoxazole (SO1-4) derivatives against human hCA I and II isoforms and AChE. In order to test synthesized derivatives' free radical scavenging potentials were the DPPH and ABTS assays. In silico studies elucidated possible binding mechanisms of inhibitors to the active site.
Anahtar Kelimeler
Carbonic anhydrase | Acetylcholinesterase | Molecular docking | Sulfaguanidine | Sulfisoxazole
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı MOLECULAR DIVERSITY
Dergi ISSN 1381-1991
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q2
Makale Dili İngilizce
Basım Tarihi 08-2023
Cilt No 27
Sayı 4
Sayfalar 1735 / 1749
Doi Numarası 10.1007/s11030-022-10527-0
Makale Linki http://dx.doi.org/10.1007/s11030-022-10527-0